Risk stratification and prediction of cancer of focal thyroid fluorodeoxyglucose uptake during cancer evaluation

Annals of Nuclear Medicine

Volumn 24, Issue 10, 2010, Pages 721-728

  Kim, Bo Hyun ^a   Na, Min A ^a   Kim, In Joo ^a   Kim, Seong Jang ^a   Kim, Yong Ki ^a  

^a Pusan National University Hospital   (South Korea)

Author keywords

F 18 FDG PET CT; SUV; Thyroid incidentaloma

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; BENIGN TUMOR; CANCER PATIENT; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PREDICTOR VARIABLE; PREVALENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STRATIFIED SAMPLE; THYROID CANCER; THYROID INCIDENTALOMA;

BIOLOGICAL TRANSPORT; CELL DIFFERENTIATION; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; INCIDENTAL FINDINGS; MALE; MIDDLE AGED; OBSERVER VARIATION; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; ROC CURVE; THYROID GLAND; THYROID NEOPLASMS; THYROID NODULE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 78751566595     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12149-010-0414-6     Document Type: Article

References (25)

1. GH Tan H Gharib 1997 Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging Ann Intern Med 126 226 231 1:STN:280:DyaK2s7lvV2gtg%3D%3D 9027275
2. L Hedegus 2004 Clinical practice: the thyroid nodule N Engl J Med 351 1764 1771 10.1056/NEJMcp031436 (Pubitemid 39383211)
3. B Burguera H Gharib 2000 Thyroid incidentalomas prevalence, diagnosis, significance, and management Endocrinol Metab Clin North Am 29 187 203 1:STN:280:DC%2BD3c7ps1yhsg%3D%3D 10732271 10.1016/S0889-8529(05)70123-7
4. N Oriuchi T Higuchi T Ishikita M Miyakubo H Hanaoka Y Iida, et al. 2006 Present role and future prospects of positron emission tomography in clinical oncology Cancer Sci 97 1291 1297 1:CAS:528:DC%2BD28Xht1Ogur3E 17052261 10.1111/j.1349-7006.2006.00341.x (Pubitemid 44614979)
5. 18FDG-PET in the follow-up of patients with colorectal cancer Br J Cancer 98 875 880 1:STN:280: DC%2BD1c7lvF2ntQ%3D%3D 18301402 10.1038/sj.bjc.6604263 (Pubitemid 351341613)
6. B Kasper S Dietrich A Dimitrakopoulou-Strauss LG Strauss U Haberkorn AD Ho, et al. 2008 Early prediction of therapy outcome in patients with high-risk soft tissue sarcoma using positron emission tomography Onkologie 31 107 112 18322413 10.1159/000113795 (Pubitemid 351348089)
7. 18F-fluorodeoxyglucose positron emission tomography imaging in surgery for pancreatic cancer World J Gastroenterol 14 64 69 18176963 10.3748/wjg.14.64 (Pubitemid 351314328)
8. A Loft AK Berthelsen H Roed C Ottosen L Lundvall J Knudsen, et al. 2007 The diagnostic value of PET/CT scanning in patients with cervical cancer: a prospective study Gynecol Oncol 106 29 34 17482666 10.1016/j.ygyno.2007.03.027 (Pubitemid 46908743)
9. LF Geus-Oei WJ Oyen 2008 Predictive and prognostic value of FDG-PET Cancer Imaging 8 70 80 18390390 10.1102/1470-7330.2008.0010 (Pubitemid 351517292)
10. M Hutchings L Specht 2008 PET/CT in the management of haematological malignancies Eur J Haematol 80 369 380 18284629 10.1111/j.1600-0609.2008.01051.x (Pubitemid 351503112)
11. LF de Geus-Oei HF van der Heijden FH Corstens WJ Oyen 2007 Predictive and prognostic value of FDG-PET in nonsmall-cell lung cancer: a systematic review Cancer 110 1654 1664 17879371 10.1002/cncr.22979 (Pubitemid 47557290)
12. 18F-fluorodeoxyglucose by thyroid in patients with nonthyroidal head and neck cancers Clin Endocrinol 67 135 139 10.1111/j.1365-2265.2007.02850.x (Pubitemid 46955453)
13. TY Kim WB Kim JS Ryu G Gong SJ Hong YK Shong 2005 18F-fluorodeoxyglucose uptake in thyroid from positron emission tomography (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma Laryngoscope 115 1074 1078 15933524 10.1097/01.MLG.0000163098.01398.79 (Pubitemid 40777005)
14. S Kurata M Ishibashi Y Hiromatsu H Kaida I Miyake M Uchida, et al. 2007 Diffuse and diffuse-plus-focal uptake in the thyroid gland identified by using FDG PET: prevalence of thyroid cancer and Hashimoto's thyroiditis Ann Nucl Med 21 325 330 17705011 10.1007/s12149-007-0030-2 (Pubitemid 47283256)
15. 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET-CT Nucl Med Comm 28 373 381 10.1097/MNM.0b013e3280964eae (Pubitemid 46569170)
16. 18F- fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects J Clin Endocrinol Metab 88 4100 4104 1:CAS:528:DC%2BD3sXntlahurw%3D 12970270 10.1210/jc.2003-030465 (Pubitemid 37153705)
17. A van den Bruel A Maes T de Potter L Mortelmans M Drijkoningen B Van Damme, et al. 2002 Clinical relevance of thyroid fluorodeoxyglucose whole body positron emission tomography incidentaloma J Clin Endocrinol Metab 87 1517 1520 11932274 10.1210/jc.87.4.1517 (Pubitemid 34615231)
18. MS Cohen N Arslan F Dehdashti GM Doherty TC Lairmore MB Brunt, et al. 2001 Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose positron emission tomography Surgery 130 941 946 1:STN:280:DC%2BD3MjgtFensw%3D%3D 11742321 10.1067/msy.2001.118265 (Pubitemid 34014558)
19. 18F-FDG PET/CT: clinical significance and improved characterization J Nucl Med 47 609 615 16595494
20. JG Yi EM Marom MT Truong HA Macapinlac GW Gladish BS Sabloff, et al. 2006 Focal uptake of fluorodeoxyglucose by the thyroid in patients undergoing initial disease staging with combined PET/CT for non-small cell lung cancer Radiology 236 271 275 10.1148/radiol.2361041007
21. Gough J, Scott-Coombes D, Fausto Palazzo F. Thyroid incidentaloma: an evidence-based assessment of management strategy. World J Surg. 2008 (epub ahead of print). doi: 10.1007/s00268-008-9503-2.
22. S Yasuda M Ide 2005 PET and cancer screening Ann Nucl Med 19 167 177 15981668 10.1007/BF02984601
23. 18F-fluorodeoxyglucose positron emission tomography does not predict malignancy in thyroid nodules cytologically diagnosed as follicular neoplasm J Clin Endocrinol Metab 92 1630 1634 1:CAS:528:DC%2BD2sXlt1Oksbk%3D 17284624 10.1210/jc.2006-2311 (Pubitemid 46997163)
24. 18F-fluorodeoxyglucose positron emission tomography in preoperative assessment of cytologically indeterminate thyroid nodules J Clin Endocrinol Metab 92 4485 4488 1:CAS:528:DC%2BD2sXhtlartbjF 17684046 10.1210/jc.2007-1043 (Pubitemid 350074775)
25. Y Liu 2009 Clinical significance of thyroid uptake in F18-fluorodeoxyglucose positron emission tomography Ann Nucl Med 23 17 23 19205834 10.1007/s12149-008-0198-0